Primary pulmonary vasculature tumors are exceptionally rare, with only a few reported cases. Signs and symptoms of such neoplasms vary but include dyspnea, cough, and chest pain. This condition is associated with a high mortality rate and is easily misdiagnosed as a pulmonary artery embolism. We present a case of pulmonary artery sarcoma that demonstrates the value of cardiac magnetic resonance imaging for accurate diagnosis.
Primary pulmonary vasculature tumors are exceptionally rare, with only a few reported cases. Signs and symptoms of such neoplasms vary but include dyspnea, cough, and chest pain. This condition is associated with a high mortality rate and is easily misdiagnosed as a pulmonary artery embolism. We present a case of pulmonary artery sarcoma that demonstrates the value of cardiac magnetic resonance imaging for accurate diagnosis.
B ecause pulmonary artery sarcomas are rare and present with nonspecific signs, symptoms, and imaging fi ndings, they are easily misdiagnosed as acute or chronic thromboembolic disease of the pulmonary arteries. As a result, the opportunity for early diagnosis of this aggressive neoplasm is missed. We present a case of pulmonary artery sarcoma that was confi rmed by biopsy when imaging studies initially misdiagnosed it as an embolism.
CASE REPORT
A 44-year-old male truck driver with no signifi cant past medical history presented to the emergency department with a few month history of progressive productive cough with white phlegm, which was occasionally blood tinged and associated with shortness of breath. He denied any history of fever, chills, malaise, or chest pain, as well as smoking, alcohol, or illegal drug use. His oxygen saturation was 94% on room air, and the rest of the examination was unremarkable except for hoarseness and grade III/VI systolic murmur noted at the left second intercostal space with radiation to the carotid and scapula.
A CT angiogram of the chest was remarkable for a hypodense, occlusive fi lling defect of the main pulmonary artery extending to the lobar and segmental branches and with polypoid extension along the superior wall of the left main pulmonary artery (Figure 1a, 1b) . No evidence of right heart Spindle-cell sarcoma involving the major pulmonary arteries systemic chemotherapy with Adriamycin 75 mg/m 2 continuous infusion and dacarbazine 1000 mg/m 2 in preparation for cardiovascular surgery.
DISCUSSION
Angiosarcomas are rare vascular tumors with a prevalence of <1%; they account for only 2% to 3% of all soft tissue sarcomas in adults (1-3). Most of these sarcomas grow along the intimal surface of the vessel in a sheet-like manner (intimal sarcoma) and are believed to originate from pluripotent mesenchymal cells of the intima. Less commonly, pulmonary artery sarcomas arise from the muscular wall or adventitia of the vessel.
Th e most common clinical manifestation of pulmonary artery sarcoma is dyspnea. Others include chest pain, cough, hemoptysis, weight loss, syncope, and fever, all of which are nonspecifi c (4). Th ese extremely rare tumors are usually indistinguishable from acute or chronic thromboembolic disease of pulmonary arteries. A case series by Srivali et al showed that all nine patients diagnosed with pulmonary artery sarcoma had a fi lling defect in the main, right, and left pulmonary artery on CT scan (5). Conventional diagnostic radiologic approaches such as CT and echocardiography can detect masses and thrombus based on anatomical appearance rather than tissue characteristics (6) .
CMRI is an established technique in the evaluation and characterization of tissue from cardiac masses that can be extremely helpful in suggesting the preoperative diagnosis of an intraluminal pulmonary artery neoplasm based on intrinsic diff erences in hydrogen strain was noted. Chest x-ray was normal and laboratory investigations, including those for hypercoagulable disorders, were within normal limits. A diagnosis of pulmonary artery embolism was made based on the clinical presentation and initial imaging results. After the patient was admitted and treated with anticoagulation, his symptoms temporarily subsided and he was discharged to follow up with his primary care physician.
After a few weeks, the patient returned to the hospital with worsening symptoms. A repeat CT scan of the chest showed no changes compared to the previous scan (Figure 1c, 1d) , raising the possibility of an infi ltrative tumor mass. Cardiac magnetic resonance imaging (CMRI) demonstrated a solid mural mass infi ltrating the wall of the main pulmonary artery. Th e mass exhibited heterogeneous peripheral enhancement on delayed enhancement imaging because of fi brosis and central focal hypointensity due to central necrosis. First-pass perfusion imaging of the mass demonstrated arterial phase enhancement due to increased vascularity. Finally, the mass showed a heterogeneous pattern of signal intensity in turbo spin echo imaging with both T1-and T2-weighted imaging. Th ese fi ndings were consistent with tumor tissue necrosis and hemorrhage from a primary intimal sarcoma of the pulmonary artery (Figure 2) . proton density and T1 and T2 relaxation properties of the mass (7). Th is technique has been well validated in diff erentiating a thrombus from a tumor compared to reference standards of both pathology and clinical outcomes (8) . Th e T1-and T2-weighted signal characteristics of a thrombus vary depending on its age. Chronic organized thrombus becomes water depleted and cellular debris containing methemoglobin is replaced by fi brous tissue. Th is greater fi brin content leads to a lower signal intensity on both T1-and T2-weighted images. Contrast-enhanced CMRI allows diff erentiation between thrombus and surrounding myocardium because thrombus is avascular and hence is characterized by an absence of contrast uptake (9) .
Angiosarcomas present macroscopically as large grossly hemorrhagic infi ltrative masses with areas of necrosis. Th ese attributes are refl ected on CMRI, which typically shows a large mass with heterogeneous appearance on T1-weighted images with areas of intermediate, low, and high signal intensity refl ecting tumor tissue, necrosis, and the presence of methemoglobin. Th ese tumors have a heterogeneous, predominantly hyperintense appearance on T2-weighted images and a heterogeneous enhancement pattern after administration of gadolinium contrast material with marked surface enhancement; a sun ray appearance has also been described (10, 11) .
Surgical resection is the mainstay of treatment. When appropriate, surgical intervention should not be delayed, as the tumor is aggressive and fast growing and there have been suggestions of improved patient outcomes from earlier diagnosis and resection (12) . Th e value of radiation therapy and/or chemotherapy is still equivocal (13, 14) . Despite surgical removal of the tumor, prognosis is very poor. In the case series by Srivali et al, eight of the nine patients studied were diagnosed while alive (5) . Of the eight, fi ve died within a mean duration of 2.1 years following diagnosis. Two of the remaining three had recurrences and metastases at 23 and 27 months following diagnosis. Only one remained alive and disease-free. Another report of three cases of pulmonary artery sarcoma by Zhu et al recorded deaths of these patients within an 18-month period following surgical resection (15) .
